Addressing unmet medical needs.
Addressing Unmet Medical Needs with Stem Cell Culture Supernatant: Drug Discovery Bio-Venture U-Factor Co., Ltd.
U-Factor® Solution for Unmet Medical Needs.
Bringing U-Factor® solution to the world.
Many diseases, such as ALS and Alzheimer's disease, still exist in the world without effective treatments. We are committed to continuously developing new drugs to address the unmet medical needs of these intractable diseases using our developed stem cell culture supernatant, U-Factor® solution.
Research and Development
Addressing Unmet Medical Needs with U-Factor® Solution
In July 2023, we discovered a stem cell culture supernatant with higher cellular activity than conventional ones. We established an automated culturing method for mass production and began offering it as a "cell activator," known as U-Factor® solution, while continuing further research and development.
- ALS (Amyotrophic Lateral Sclerosis)
- Glaucoma
- Dry Eye
- Post-Stroke Sequelae
- Alzheimer's Disease
- Cerebral Aneurysm
- Muscular Dystrophy
- Crohn's Disease
- Parkinson's Disease
Collaborative Research and Specific Clinical Research
We are conducting research on various topics in collaboration with research institutions.
Current Partners
-
![AIST Solutions]()
AIST Solutions
-
![Keio University School of Medicine]()
Keio University School of Medicine
-
![Tokyo Women's Medical University]()
Tokyo Women's Medical University
-
![The Jikei University School of Medicine]()
The Jikei University School of Medicine
News Release
-
Press Release
Dr. Yuji Teramura Receives Society Award at the 51st Annual Meeting of the Japanese Society for Organ Preservation and Biology
-
Press Release
Hitonowa Medical Clinic Receives “Excellence Award” at the 24th Congress of the Japanese Society for Regenerative Medicine
-
Information
Dr. Yuji Teramura Receives the 2024 AIST President’s Award